Nymox Pharmaceutical Corp (NASDAQ:NYMX)

1.33
Delayed Data
As of Jul 02
 -0.01 / -0.75%
Today’s Change
0.33
Today|||52-Week Range
5.75
+232.50%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close1.34
Today’s open1.34
Day’s range1.31 - 1.34
Volume40,621
Average volume (3 months)1,045,207
Market cap$49.5M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-12.19%
P/E ratioNM
Price/Sales4.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc+0.24+1.36%
ACURAcura Pharmaceutical...-0.02-2.31%
IMNPImmune Pharmaceutica...0.000.00%
HEBHemispherx Biopharma...+0.00+1.58%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 14, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$2.9M
Annual profit (last year)-$4.6M
Net profit margin-155.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer, Secretary &
Treasurer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers